Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: A randomised trial

Lancet

Volumn 355, Issue 9206, 2000, Pages 798-803

  Dilraj, Athmanundh ^a   Cutts, Felicity T ^b   De Castro, J Fernandez ^c   Wheeler, Jeremy G ^b   Brown, David ^d   Roth, Cathy ^d   Coovadia, Hoosen M ^e   Bennett, John V ^f  

^a SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c Center of Health Systems Research Mexican Institute of Public Health   (Mexico)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

^e UNIVERSITY OF KWAZULU NATAL   (South Africa)

^f EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES ANTIBODY; MEASLES VACCINE;

ADOLESCENT; AEROSOL; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL TRIAL; CONJUNCTIVITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIARRHEA; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG POTENCY; FEVER; HEADACHE; HUMAN; IMMUNOGENICITY; INFECTION CONTROL; MAJOR CLINICAL STUDY; MEASLES; MULTICENTER STUDY; NEBULIZATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; RHINITIS; SORE THROAT; SOUTH AFRICA;

EID: 0034603548     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)95140-1     Document Type: Article

References (27)

1. Peltola H, Heinonen OP, Valle M, et al. The elimination of indigenous measles, mumps and rubella from Finland by a 12 year, two-dose vaccination program. N Engl J Med 1994; 331: 1397-402.
2. Expanded Programme on Immunization. Accelerated measles strategies. Wkly Epidemiol Rec 1994; 69: 229-36.
3. de Quadros CA, Olive JM, Hersh BS, et al. Measles elimination in the Americas. Evolving strategies. JAMA 1996; 275: 224-29.
4. Markowitz LE, Albrecht P, Orenstein WA, Lett SM, Pugliese TJ, Farrell D. Persistence of measles antibody after revaccination. J Infect Dis 1992; 166: 205-08.
5. Deseda-Tous J, Cherry JD, Spencer MJ, et al. Measles revaccination. Persistence and degree of antibody titre by type of immune response. Am J Dis Child 1978; 132: 287-90.
6. Cohn ML, Robinson ED, Faerber M, et al. Measles vaccine failures: lack of sustained measles-specific immunoglobulin G responses in revaccinated adolescents and young adults. Pediatr Infect Dis J 1994; 13: 34-38.
7. Sabin AB. Strategy for rapid elimination and continuing control of poliomyelitis and other vaccine preventable diseases of children in developing countries. BMJ 1986; 292: 531-33.
8. Sabin AB, Flores Arechiga A, de Castro JF, et al. Successful immunization of children with and without maternal antibody by aerosolized measles vaccine. I. Different results with undiluted human diploid cell and chick embryo fibroblast vaccine. JAMA 1983; 249: 2651-62.
9. Sabin AB, Flores Arechiga A, de Castro JF, et al. Successful immunization of children with and without maternal antibody by aerosolized measles vaccine. II. Vaccine comparisons and evidence for multiple antibody response. JAMA 1984; 251: 2363-71.
10. Fernandez-de-Castro J, Kumate J. La vacunacion contra el sarampion. Situacion en Mexico y America. Avances en el metodo de inmunizacion por aerosol. Bol Med Hosp Infant Mex 1990; 47: 449-61.
11. WHO, UNICEF. State of the world's vaccines and immunisation. Geneva: WHO, 1996: 1-161.
12. Fernandez-de-Castro J, Kumate J, Sepulveda J, et al. La vacunacion antisarampionosa en Mexico por el methodo de aerosol. Salud Publica Mex 1997; 39: 53-60.
13. Forsey T, Heath AB, Minor PD. The 1st international standard for anti-measles serum. Biologicals 1991; 19: 237-41.
14. Norrby E. Haemagglutination by measles virus 4. A simple procedure for production of high potency antigen for haemagglutination-inhibition (HI) tests. Proc Soc Exp Biol Med 1962; III: 814-18.
15. Samb B, Aaby P, Whittle HC, et al. Serological status and measles attack rates among vaccinated and unvaccinated children in rural Senegal. Pediatr Infect Dis J 1995; 14: 203-09.
16. Perry KR, Brown DWG, Parry JV, Panday S, Pipkin C, Richards A. Detection of measles, mumps, and rubella antibodies in saliva using antibody capture radioimmunoassay. J Med Virol 1993; 40: 235-40.
17. Cutts FT, Clements JC, Bennett, J. Alternative routes of measles immunization: a review. Biologicals 1997; 25: 323-38.
18. Cutts FT, Grabowsky M, Markowitz LE. The effect of dose and strain of live attenuated measles vaccines on serological responses in young infants. Biologicals 1995; 23: 95-106.
19. Halsey NA. Increased mortality after high titre measles vaccine: too much of a good thing. Pediatr Dis J 1993; 12: 462-65.
20. Bennett JV, Cutts FT, Katz SL. Edmonston-Zagreb measles vaccine: a good vaccine with an image problem. Paediatrics 1999; 104: 1123-24.
21. Ward B, Boulianne N, Ratnam S, et al. Cellular immunity in measles vaccine failure: demonstration of measles antigen-specific lymphoproliferative responses despite limited serum antibody production after revaccination. J Infect Dis 1995; 172: 1591-95.
22. Jaye A, Magnusen A, Whittle H. Human leukocyte antigen class I-and class II-restricted cytotoxic T lymphocyte responses to measles antigens in immune adults. J Infect Dis 1998; 177: 1282-89.
23. Hayney MS, Poland GA, Jacobson RM, et al. Relationship of HLA-DQA1 alleles and humoral antibody following measles vaccination. Int J Infect Dis 1998; 2: 143-46.
24. Hammond MG, du Toit ED, Sanchez-Maza A, et al. Genetic diversity of HLA: functional and medical implications. In: Charron D, ed. Anthropology report for sub-Saharan Africa. Paris: EDK Press, 1997: 345-52.
25. Krober MS, Stracener CE, Bass JW. Decreased measles antibody response after measles-mumps-rubella vaccine in infants with colds. JAMA 1991; 265: 2095-96.
26. Fernandez-Bracho JG, Roldan-Fernandez SG. Reaciones tempranas en escolares vacunados con antisarampionosa en aerosol. Salud Publica Mex 1990; 32: 653-57.
27. LiCalsi C, Christensen T, Bennett JV, Phillips E, Witham C. Dry powder inhalation as a potential delivery method for vaccines. Vaccine 1999; 17: 1796-803.